Porton/J-STAR at 2021 SAPA Annual Conference
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and...
Porton Announces Acquisition Of Yuyang Pharmaceutical To Expand Its Manufacturing Capacity
Chongqing, China，August 18, 2021-Porton Pharma Solutions Ltd. (Porton) today announced that it is to acquire...
Porton Reports Strong Half-Year Results
J-STAR Research Exhibiting at CPhI North America August 10-12
Visit J-STAR Research and Porton at Booth 2243 from August 10th to 12th at this month's CPhINorthAmerica...
CfPC Announces Program Of 2021 Pharmaceutical Crystallization Summit (Reproduced)
The Center for Pharma Crystallization (CfPC) at J-STAR Research, Inc., a US based subsidiary of...
CfPC Announces Program of 2021 Pharmaceutical Crystallization Summit
The Center for Pharma Crystallization (CfPC) at J-STAR Research, Inc., a US based subsidiary of...
Porton awards Industrial Crystallization Scholarship
On Saturday, June 6, Porton and Tianjin University National Engineering Research Center of Industrial Crystallization...
Porton begins construction on highly anticipated Drug Product GMP site
May 25, 2002, Shanghai, China. Porton Pharma Solutions Ltd., one of the world’s leading CDMOs,...
Structure Elucidation Equipment & Capability Update
To augment our significant in-house NMR resources, which includes 4 NMR spectrometers and 3 full-time...